been suggested that chronic use of Meth causes long-term cognitive deficits. Furthermore, Cannabidiol (CBD) has a large-spectrum therapeutic potential to treat many neuropsychiatric disorders, such as addiction. Several
Backgroud/Introduction: Cannabidiol (CBD) is a nonpsychoactive phytocannabinoid with anti-inflammatory activity mediated by enhancing adenosine signaling [1,2]. As the adenosine A1 receptor activation confers protection…
report design involving 140 subjects, consisting of people who consumed NegEnt, an original, liposomal cannabidiol-based preparation in drops for aromatherapy, for at least one month ... article, demonstrate the high…
Topical Magnesium-Coordinated Cannabidiolic Acid (CBDA) for the Treatment of Restless Leg Syndrome Restless Leg Syndrome (RLS) is multifactorial disease state with many different potential pathophysiological mechanisms…
author developed NegEnt Spray - Muscles and Joints, a topical medical device that uses liposomal cannabidiol and chamomile hydrolate to reduce inflammation and pain in musculoskeletal disorders. The liposomal technology…
permeability and to allow control over their release rate. Using two model actives – Cannabidiol (CBD) and Curcumin we developed NPs preparation process and defined the parameters influencing on size
developing group of preclinical proof shows that certain cannabinoids, including cannabidiol (CBD) and engineered subsidiaries, may assume a part in the myelinating processes and are promising little particles
opinions of aging as a disease and cannabinoids as medicine shift, further inquiry of cannabidiol application and its effects on genetic epigenetic metabolic markers and signalling pathways during aging process
Sixteen healthy, cannabis and cannabidiol (CBD) naïve patients with mild to moderate musculoskeletal pain took a single dose of 5 mg CBD sublingual tablet. Patients were using other-the-counter
treatment of patients with painful diabetic peripheral neuropathy (pDPN) of the feet. Safety of cannabidiol (CBD) sublingual tablets was the primary objective. Efficacy of the proprietary water-solubilized CBD sublingual
primary objective of this study is to evaluate the safety and efficacy of cannabidiol (CBD) sublingual tablets for the treatment of patients with chronic diabetic neuropathic pain. The secondary objects
treatment with riluzole, symptoms progressed relatively fast. Therefore, the patient decided to take cannabidiol (CBD, 2 × 200 mg/day) as co-medication, which was started 8 weeks after riluzole
therapeutic potential of various pharmacological agents, particularly those targeting the central nervous system. Cannabidiol, a non-psychoactive cannabinoid, has demonstrated neuroprotective, anti-inflammatory, and…
treatment-resistant epilepsy. This research reviews the negative and positive side effects of cannabidiol. The current research conveys a clear correlation between the use of CBD and seizure control. Although…
Cannabidiol (CBD) is the major non-psychotropic cannabinoid presents in Cannabis sativa plant. It has proved to have a potential therapeutic utility in several kinds of tumors ... nanoparticles (NPs) may resolve these…
experience unwanted side effects. Recently, there has been increasing interest in the potential of cannabidiol (CBD), a non-psychoactive component of the Cannabis sativa plant, as a treatment for anxiety
research aimed at determining the influence of one of the non-psychoactive phytocannabinoids, Cannabidiol (CBD), on metabolic processes in the development of this dermatosis. The subject of the analysis
active site of CBD? This study seeks to examine and identify the mechanisms of Cannabidiol (CBD) using the reaction of CBD oil with calf thymus DNA. HPLC (high performance liquid
have created a potential bias against the pharmacology of other potentially therapeutic cannabidnoids. Cannabidiol (CBD) is the second most plentiful cannabinoid in the Cannabis species. Importantly, this pleiotropic…
Preclinical and clinical evidence collected over the past years suggests that Cannabidiol (CBD), one of the main compounds of the plant Cannabis sativa, presents potential therapeutic activity for the treatment
main components. Hence, this ongoing work focuses on finding ways to administer cannabinoids, specifically, cannabidiol (CBD), without the presence of any of the psychoactive compounds. Extensive study in this field
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.